ZNF385B: A Potential Drug Target and Biomarker (G151126)
ZNF385B: A Potential Drug Target and Biomarker
Introduction
ZNF385B (Zinc Finger Nucleotide-conjugated) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of gene expression and has been involved in various cellular processes, including cell growth, differentiation, and inflammation. ZNF385B is a nuclear protein that is expressed in various tissues and cells, including brain, pancreas, and immune cells.
Potential Drug Target
ZNF385B is a potential drug target because it is involved in the regulation of cellular processes that are important for human health. One of the key functions of ZNF385B is to regulate the activity of chromatin-remodeling complexes, which are responsible for the dynamic regulation of gene expression. ZNF385B has been shown to play a role in the regulation of pancreatic cancer, a leading cause of cancer-related deaths worldwide.
In addition to its role in the regulation of chromatin remodeling, ZNF385B has also been shown to be involved in the regulation of inflammation. Chronic inflammation has been associated with various diseases, including cancer, obesity, and diabetes. ZNF385B has been shown to be involved in the regulation of immune cell function and has been implicated in the development of autoimmune diseases.
Biomarker
ZNF385B has also been identified as a potential biomarker for various diseases. For example, ZNF385B has been shown to be downregulated in pancreatic cancer and has been used as a biomarker for pancreatic cancer diagnosis and treatment. In addition, ZNF385B has been shown to be involved in the regulation of insulin secretion in pancreatic beta cells and has been used as a biomarker for the diagnosis of type 1 diabetes.
Expression and Function
ZNF385B is a non-coding RNA molecule that is expressed in various tissues and cells, including brain, pancreas, and immune cells. It is primarily expressed in the brain and has been shown to be involved in the regulation of neuronal function and the development of neurodegenerative diseases. ZNF385B has also been shown to be involved in the regulation of pancreatic cancer, a leading cause of cancer-related deaths worldwide. For example, ZNF385B has been shown to be downregulated in pancreatic cancer and has been used as a biomarker for pancreatic cancer diagnosis and treatment.
In addition to its role in the regulation of pancreatic cancer, ZNF385B has also been shown to be involved in the regulation of inflammation. Chronic inflammation has been associated with various diseases, including cancer, obesity, and diabetes. ZNF385B has been shown to be involved in the regulation of immune cell function and has been implicated in the development of autoimmune diseases.
Conclusion
In conclusion, ZNF385B is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its functions include the regulation of cellular processes that are important for human health, including the regulation of chromatin remodeling and the regulation of inflammation. ZNF385B is expressed in various tissues and cells, including the brain, pancreas, and immune cells. Its potential as a drug target and biomarker makes it an attractive target for future research.
Protein Name: Zinc Finger Protein 385B
Functions: May play a role in p53/TP53-mediated apoptosis
The "ZNF385B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF385B comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524